Citadel Advisors - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$20,193,000
+30.7%
19,681,000
+34.1%
0.01%0.0%
Q2 2020$15,444,000
+15.0%
14,681,000
+15.8%
0.01%0.0%
Q1 2020$13,428,000
-9.5%
12,681,0000.0%0.01%0.0%
Q4 2019$14,831,000
+38.5%
12,681,000
+18.7%
0.01%
+20.0%
Q3 2019$10,706,000
-82.1%
10,681,000
-80.9%
0.01%
-81.5%
Q2 2019$59,816,000
-13.7%
55,880,000
-11.1%
0.03%
-20.6%
Q1 2019$69,336,000
-26.3%
62,880,000
-37.0%
0.03%
-33.3%
Q4 2018$94,093,000
+7.1%
99,880,000
+47.6%
0.05%
+30.8%
Q3 2018$87,861,000
+21.2%
67,680,000
+25.1%
0.04%
+8.3%
Q2 2018$72,464,000
+72.5%
54,080,000
+52.0%
0.04%
+56.5%
Q1 2018$42,004,000
-13.1%
35,580,000
-14.4%
0.02%
-20.7%
Q4 2017$48,359,000
-31.9%
41,580,000
-30.3%
0.03%
-47.3%
Q3 2017$70,998,000
+10.0%
59,650,000
+23.9%
0.06%0.0%
Q2 2017$64,554,000
+17.1%
48,150,000
+9.1%
0.06%
+10.0%
Q1 2017$55,141,000
+73.1%
44,150,000
+59.7%
0.05%
+56.2%
Q4 2016$31,859,000
-15.7%
27,650,000
-12.6%
0.03%
-15.8%
Q3 2016$37,812,000
+6.7%
31,650,000
-7.3%
0.04%
-2.6%
Q2 2016$35,439,00034,150,0000.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders